ArticleOncoTargets and therapy2021

Early Prediction of Objective Response of Fibrinogen in a Real-World Cohort of Hepatocellular Carcinoma Cases Treated by Programmed Cell Death Receptor-1 and Lenvatinib.

Yanjun Shen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.